Literature DB >> 27659711

[Pulmonary manifestations in collagen vascular diseases].

M N A Vogel1,2, M Kreuter3,4, H-U Kauczor5,4, C-P Heußel6,5,4.   

Abstract

CLINICAL/METHODICAL ISSUE: Pulmonary complications are frequent in patients with collagen vascular diseases (CVD). Frequent causes are a direct manifestation of the underlying disease, side effects of specific medications and lung infections. STANDARD RADIOLOGICAL
METHODS: The standard radiological procedure for the work-up of pulmonary pathologies in patients with CVD is multidetector computed tomography (MDCT) with thin-slice high-resolution reconstruction. PERFORMANCE: The accuracy of thin-slice CT for the identification of particular disease patterns is very high. The pattern of usual interstitial pneumonia (UIP) representing the direct pulmonary manifestation of rheumatoid arthritis (RA) can be identified with a sensitivity of 45 % and a specificity of 96 %. ACHIEVEMENTS: Both direct pulmonary manifestations, drug-induced toxicity and certain infections can have a similar appearance in thin-slice MDCT in various forms of CVD. Knowledge of the patterns and causes contributes to the diagnostic certainty. PRACTICAL RECOMMENDATIONS: At first diagnosis of a CVD and associated pulmonary symptoms thin-slice MDCT is recommended. Clinical, lung function and imaging follow-up examinations should be performed every 6-12 months depending on the results of the MDCT. In every case the individual CT morphological patterns of pulmonary involvement must be identified. The combination of information on the anamnesis, clinical and imaging results is a prerequisite for an appropriate disease management.

Entities:  

Keywords:  Causes; Computed tomography; Interstitial lung disease; Patterns; Pulmonary involvement

Mesh:

Year:  2016        PMID: 27659711     DOI: 10.1007/s00117-016-0157-z

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  30 in total

1.  Rheumatoid lung nodule.

Authors:  Parikshit Sagdeo; Yathish Gattimallanahali; Girish Kakade; Balakrishnan Canchi
Journal:  BMJ Case Rep       Date:  2015-10-29

Review 2.  Systemic sclerosis: a world wide global analysis.

Authors:  Paola Coral-Alvarado; Aryce L Pardo; Natalia Castaño-Rodriguez; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Clin Rheumatol       Date:  2009-03-11       Impact factor: 2.980

3.  Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern.

Authors:  Deborah Assayag; Brett M Elicker; Thomas H Urbania; Thomas V Colby; Bo Hyoung Kang; Jay H Ryu; Talmadge E King; Harold R Collard; Dong Soon Kim; Joyce S Lee
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

Review 4.  Interstitial lung disease in systemic lupus erythematosus.

Authors:  G S Cheema; F P Quismorio
Journal:  Curr Opin Pulm Med       Date:  2000-09       Impact factor: 3.155

5.  Thoracic manifestations of collagen vascular diseases.

Authors:  Julia Capobianco; Alexandre Grimberg; Bruna M Thompson; Viviane B Antunes; Dany Jasinowodolinski; Gustavo S P Meirelles
Journal:  Radiographics       Date:  2012 Jan-Feb       Impact factor: 5.333

6.  Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis.

Authors:  R A Matthay; M I Schwarz; T L Petty; R E Stanford; R C Gupta; S A Sahn; J C Steigerwald
Journal:  Medicine (Baltimore)       Date:  1975-09       Impact factor: 1.889

Review 7.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

Review 8.  Lung disease related to collagen vascular disease.

Authors:  David A Lynch
Journal:  J Thorac Imaging       Date:  2009-11       Impact factor: 3.000

Review 9.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

Review 10.  Pulmonary manifestations of Sjögren's syndrome.

Authors:  H C Cain; P W Noble; R A Matthay
Journal:  Clin Chest Med       Date:  1998-12       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.